Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2733-2739

  Katayama, Shigeji ^a   Oda, Kenji ^a   Ohgitani, Toshiaki ^a   Hirahara, Tadashi ^a   Shimizu, Yukio ^a  

^a Kyoto Biken Laboratories   (Japan)

Author keywords

Aluminum gel; Lablaboside F saponin; Oil based adjuvant; Particulate antigen; Soluble antigen

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; PSEUDORABIES VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HERPESVIRUS 1, SUID; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; SAPONINS;

EID: 0033522941     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00499-X     Document Type: Article

References (29)

1. Beck L., Spiegelberg H.L. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant. Cell Immunol. 123:1989;1-8.
2. Brewer J.M., Conacher M., Satoskar A., Bluethmann H., Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur. J. Immunol. 26:1996;2062-2066.
3. Germann T., Bongartz M., Dlugonska H., Hess H., Schmitt E., Kolbe L., Kolsch E., Podlaski F.J., Gately M.K., Rude E. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:1995;823-829.
4. Gupta R.K., Siber G.R. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals. 22:1994;53-63.
5. Kalish M.L., Check I.J., Hunter R.L. Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants and lipopolysaccharide on isotype selection. J. Immunol. 146:1991;3583-3590.
6. Lindblad E.B., Elhay M.J., Silva R., Appelberg R., Andersen P. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun. 65:1997;623-629.
7. Mark A., Bjorksten B., Granstrom M. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine. 13:1995;669-673.
8. Bomford R., Stapleton M., Winsor S., McKnight A., Andronova T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res. Hum. Retroviruses. 8:1992;1765-1771.
9. Britt W., Fay J., Seals J., Kensil C. Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J. Infect. Dis. 171:1995;18-25.
10. Hancock G.E., Speelman D.J., Frenchick P.J., Mineo-Kuhn M.M., Baggs R.B., Hahn D.J. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine. 13:1995;391-400.
11. Newman M.J., Wu J.Y., Gardner B.H., Munroe K.J., Leombruno D., Recchia J., Kensil C.R., Coughlin R.T. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol. 148:1992;2357-2362.
12. Maes R.K., Schutz J.C. Evaluation in swine of a subunit vaccine against pseudorabies. Am. J. Vet. Res. 44:1983;123-125.
13. Yamanaka M., Hiramatsu K., Hirahara T., Okabe T., Nakai M., Sasaki N., Goto N. Pathological studies on local tissue reactions in guinea pigs and rats caused by four different adjuvants. J. Vet. Med. Sci. 54:1992;685-692.
14. Yang C., Collins W.E., Xiao L., Patterson P.S., Reed R.C., Hunter R.L., Kaslow D.C., Lal A.A. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1). Parasite Immunol. 18:1996;547-558.
15. Aramaic Y., Suda H., Tsuchiya S. Interferon-gamma inductive effect of liposomes as an immunoadjuvant. Vaccine. 13:1995;1809-1814.
16. Gupta R.K., Siber G.R. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine. 13:1995;1263-1276.
17. Katz D., Lehrer S., Galan O., Lachmi B.E., Cohen S. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice. FEMS Microbiol. Immunol. 3:1991;305-320.
18. Katayama S., Okada N., Yoshiki K., Okabe T., Shimizu Y. Protective effect of glycoprotein gC-rich antigen against pseudorabies virus. J. Vet. Med. Sci. 59:1997;657-663.
19. Katayama S, Yamanaka M, Ota S, Shimizu Y. A new quantitative method for rabies virus by detection of nucleoprotein in virion using ELISA. J Vet Med Sci 1998 (in preparation).
20. Kensil C.R., Patel U., Lennick M., Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146:1991;431-437.
21. Balkovic E.S., Florack J.A., Six H.R. Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms. Antiviral Res. 8:1987;151-160.
22. Fujimaki H., Ozawa M., Imai T., Kubota K., Watanabe N. Adjuvant effects of aluminum silicate on IgE and IgG1 antibody production in mice. Int. Arch. Allergy Appl. Immunol. 75:1984;351-356.
23. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1988;1022-1027.
24. Schijns V.E., Haagmans B.L., Horzinek M.C. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice. J. Immunol. 155:1995;2525-2532.
25. Coughlin R.T., Fish D., Mather T.N., Ma J., Pavia C., Bulger P. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21. J. Infect. Dis. 171:1995;1049-1052.
26. Kensil C.R., Barrett C., Kushner N., Beltz G., Storey J., Patel U., Recchia J., Aubert A., Marciani D. Development of a genetically engineered vaccine against feline leukemia virus infection. J. Am. Vet. Med. Assoc. 199:1991;1423-1427.
27. Santos W.R., Bernardo R.R., Pecanha L.M., Palatnik M., Parente J.P., de Sousa C.B. Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani. Vaccine. 15:1997;1024-1029.
28. Campbell J.B. Saponins. Stewart-Tull D.E.S., The theory and practical application of adjuvant. 1995;95-128 John Wiley & Sons Ltd, West Sussex.
29. ten Hagen T.L., Sulzer A.J., Kidd M.R., Lal A.A., Hunter R.L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J. Immunol. 151:1993;7077-7085.